Yogesh Bramhecha, PhD

Yogesh Bramhecha, PhD has over twelve years of experience in the biopharmaceutical industry. Yogesh began their career in 2009 as a Medical Sales Representative for Trio Pharma. In 2011, they became an Immuno-Oncology Graduate Intern for the Centre for Translational Research in Cancer at McGill University. In 2012, they became a Translational-Clinical Oncology Research Fellow (Ph.D.) at McGill University. Yogesh'sfellowship included identifying and validating novel genomic biomarkers for optimum risk stratification of prostate cancer patients, co-inventing a biomarker patent application, and authoring high-impact oncology publications. In 2016, they became a Scientific Expert- Clinical Research Ethics Board (Oncology Trials group) at the Centre universitaire de santé McGill | McGill University Health Centre. Yogesh'sresponsibilities included performing in-depth scientific evaluation of proposed clinical studies, leading investigators/ sponsors to implement the REB recommendations, and critically assessing clinical trials regulatory documents. In 2017, they became a Scientific Project Manager (Pharma Biomarker Liaison) for Trans-Hit Biomarkers, Inc. In 2018, they became the Director, Clinical-Translational Research (Immuno-Oncology) for IMV Inc. where they established a new translational research department and led the strategic development, execution, and delivery of translational biomarker pipelines to support clinical trials across different tumor types. Finally, in 2022, they became the Director, Biomarker Discovery for Janux Therapeutics.

Yogesh Bramhecha, PhD has an extensive educational background. Yogesh earned their Doctor of Philosophy (Ph.D.) in Experimental Medicine (Translational Oncology) from McGill University, a Master Applied in Biotechnology from McGill University, a Master of Science (M.Sc.) in Biotechnology from Savitribai Phule Pune University, and a Bachelor of Science (B.Sc.) in Biotechnology from Sinhgad College of Science, Savitribai Phule Pune University. In addition, they have obtained several certifications, including Basic Business Skills (BBS) Certification from McGill University, Certified Training in Bio-safety and Hazardous waste disposal from McGill University, Certified Training in Radiation Safety from McGill University, DL101- General Course in Intellectual Property from the World Intellectual Property Organization, Primer on IPR & Introduction to Patent Cooperation treaty from the World Intellectual Property Organization, DL204- Advanced Course: Biotechnology and Intellectual Property from the World Intellectual Property Organization, and Good Clinical Practices (GCP) Certification from the Centre universitaire de santé McGill et IR-CUSM | McGill University Health Centre and RI-MUHC.